NA Proactive news snapshot: Mountain Valley MD, Zynerba Pharmaceuticals, TRACON Pharmaceuticals, Kainantu Resources, Ready Set Gold UPDATE …
A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires
() (FRA:20MP) (OTCQB:MVMDF) announced that it has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials with third-party cancer Contract Research Organizations (CROs) in triple-negative breast cancer, metastatic melanoma, and lung carcinoma. Mountain Valley MD said the cancer patent has been filed for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad chemotherapeutic to immunotherapeutic cancer regimens. The company noted that it is proceeding with three separate pre-clinical trials with specialized third-party cancer CROs: (1) triple-negative breast cancer; (2) metastatic melanoma; and (3) Lewis Lung Carcinoma as a proxy for non-small cell lung carcinoma.
Inc () has received guidance from the US Food and Drug Administration (FDA) on a confirmatory Phase 3 trial of Zygel in patients with Fragile X syndrome (FXS). The trial, which will be called RECONNECT (A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome), is designed to evaluate the efficacy and safety of Zygel in children and adolescents with FXS. The company said it believes that the results, if positive, from RECONNECT will be sufficient to support the submission of a New Drug Application for Zygel in patients with FXS.
Inc () ended the first quarter of 2021 on March 31 with cash and equivalents of $30.4 million, which it said will fund its operations into the second half of 2022. The company also noted that as of May 5, it has initiated 22 US clinical sites and enrolled more than 20 patients in the pivotal ENVASARC trial of single-agent envafolimab and envafolimab combined with Yervoy, which has triggered the initial Data Monitoring Committee review of safety data from each cohort.
() has reported high-grade sampling results for the East Avaninofi prospect at its KRL South project in Papua New Guinea, which included 40.13 grams per tonne (g/t) gold. The company also said its exploration campaign at KRL South has identified three distinct gold prospects with epithermal, skarn and porphyry-style mineralisation. “Building on earlier work, I am pleased to report that KRL’s focused exploration programme has resulted in us defining three prospects in a relatively short period of time,” Kainantu Resources CEO Matthew Salthouse said in a statement.
Ready Set Gold Corp () (OTCPINK:RDYFF) (FRA:0MZ) revealed the final set of drill results from the Phase 1 program at its flagship Northshore gold project showing all seven holes intersected gold mineralization. Highlights from the results include one hole that intersected 80 metres (m) at 1.1 grams per ton (g/t) gold, including 11.2m at 3.5 g/t that hosted a higher-grade interval of 5m at 7.3 g/t gold. Two other holes intersected 86.5m of 0.9 g/t gold, including 10.5m at 3 g/t, and 2m at 27.3 g/t gold.
Corp () has announced results for its fiscal 2021 second quarter and laid out a path to “much higher revenue levels” as its complex infrastructure programs shift into gear. For the three months ended April 30, 2021, IEC reported revenue of $45.4 million, a year-over-year increase of 2.7% from $44.2 million at the same stage in 2020. Gross profit was $3.3 million, 7.3% of sales, compared to gross profit of $5.5 million, 12.5% of sales in the second quarter of fiscal 2020. The company reported a net loss of $300,000, $0.03 per diluted share, compared to net income of $1.5 million, $0.14 per diluted share, a year earlier. “Second fiscal quarter results came in below expectations due to delays in ramping two high-value programs,” IEC CEO Jeffrey Schlarbaum said in a statement. “We believe we have built an infrastructure to support the conversion of much higher revenue levels that have now shifted into the second half of the fiscal year.”
. () (FRA:5VR) (OTCBB:VRRCF) revealed that it has received “convincing” final data for the ground-based gravity survey carried out in March over the carbonatite complex on its Hecla-Kilmer property, in Northern Ontario. “The result is obvious: the intervals of copper, gold and critical metal mineralization intersected last fall by VR are located on the eastern margin of a large and high amplitude gravity anomaly,” said the company. VR Resources said it is now planning for Phase II, follow-up drilling in September to test the new anomaly for the heart of the “REE-bearing, IOCG hydrothermal breccia system discovered at Hecla-Kilmer in 2020.”
() said it has been selected in a US Department of Energy National Energy Technical Laboratory (NETL) contract as a consortium member to assess Northern Appalachian critical and rare earth elements (REE). Specifically, the Consortium to Assess Northern Appalachia Resource Yield (CANARY) is led by Penn State and includes American Resources. The award targets REE and critical mineral recoveries from waste streams. The company said the grant — Carbon Ore, Rare Earth and Critical Minerals (CORE-CM) Initiatives for US Basins — will assess and catalog Northern Appalachian sources of REEs and critical minerals, assess and develop strategies used to recover REEs and critical minerals, assess the infrastructure, industries, and businesses to determine supply chain gaps, and formulate plans to establish Technology Innovation Centers.
DRDGOLD Limited () (), the South Africa-focused mine tailings specialist, has reported a fall in gold production in its latest quarter, despite an increase in the amount of ore processed. DRDGold is majority-owned by Sibanye-Stillwater, the major platinum group metals (PGMs) and gold producer. It operates the Ergo Mining Operations (EMO) business on the eastern Witwatersrand, and also the Far West Gold Recoveries (FWGR) project. In a statement covering its first quarter to March 31, 2021, the miner said there was a 6% quarter-on-quarter reduction in gold output to 1,382 kilogram (kg), despite a 3% increase in the ore milled.
Corp. () said it has hired Mark Bradley, previously Barrick Gold’s Cortez Project team leader during the discovery and definition of the multi-million-ounce Goldrush deposit, as its VP of Exploration. Cortez and Goldrush are located just some five kilometres to the northwest and north respectively of ‘s Golden Trend project. For the Cortez and Goldrush discovery, he was a co-recipient of the prestigious Thayer Lindsley Award for International Mineral Discovery from the Prospectors and Developers Association of Canada. During the Goldrush discovery program, he guided and managed the Cortez exploration team of 20+ geologists and over two hundred contracting personnel.
() has announced that its chairman and CEO, Evan Sohn, will present the results of the company’s Recruiter Index for April 2021 live on CNBC this Thursday, May 6, 2021, on “The Exchange,” which airs 1.00pm to 2.00pm ET. The Recruiter Index is a survey of the Recruiter.com recruiter network, which is comprised of more than 27,750 small and independent recruiters. It has a successful track record of forecasting the Labor Department’s jobs report by relying on the sentiment of recruiters. “Month after month, we continue to generate a wealth of data across the hiring and jobs landscape as our network of on-the-ground expert recruiters continues to grow, providing invaluable insight into areas of business that show immense potential for growth as the US economy continues to build back. I am excited to once again share the latest results with the CNBC audience,” said Sohn.
CleanSpark, Inc. () has announced that it will hold the company’s second-quarter 2021 live virtual earnings presentation and business update for investors and analysts on May 7, 2021, at 8.00am PST / 11.00am EST. To participate in the virtual meeting, investors can use the following link: https://globalmeet.webcasts.com/starthere.jsp?ei=1408452&tp_key=56b26c1000. A transcription of event will be available on the company’s website after the event at www.cleanspark.com.
GameSquare Esports Inc () (), through its Gaming Community Network (GCN) division, has signed a sales partnership with Even Matchup Gaming (EMG). The company said EMG owns and operates major esports events, including Get On My Level, the largest fighting game tournament in Canada, and Let’s Make Moves, the largest Super Smash Bros event in the New York area. “We see a lot of potential in helping EMG’s team maximize their sales pipeline,” said Justin Kenna, CEO of GameSquare, in a statement.
() () () has announced a partnership with LeadGen Labs, a custom synthesis and contract research organization, to support Mydecine’s novel psychedelic drug development efforts and increase the number of novel molecules the company can synthesize concurrently. Following the announcement of the company’s four initial drug candidates, the Denver-based company said it and LeadGen Labs will work to synthesize novel psychedelic molecules. Mydecine said LeadGen Labs, which provides expertise in custom synthesis and route design, will work with the company’s research and drug design team to target these novel molecular entities and enhanced formulations, including effective dosages and safety.
Corporation () (FRA:2C1) announced it is launching a new, packaged version of its customer relationship management software iAgent. The CRM software is designed for small-to-medium enterprises (SMEs) to respond faster to leads, improve customer service and optimize work flow. Toronto-based Xigem said the updated iAgent is an “out-of-the-box” version.
() () announced record sales of C$10.7 million during the month of April, including a single-day record of US$543,000 on April 20 (aka 4/20), as tourism returns to Las Vegas. The company’s April sales nearly totaled its sales from the entirety of the second quarter of 2020, which came in at C$10.8 million. Gross margins for the month were in excess of 50%. Planet 13 attributed the surge to increased tourist activity as pandemic restrictions wind down, on top of strong wholesale results and continued growth of its Medizin dispensary.
MedX Health Corporation () (OTCMKTS:MDXHF) (FRA:9MH) announced the appointment of Sylvain Desjeans as the company’s new chief revenue officer. MedX said Desjeans will help the company accelerate its sales in North America and internationally with his marketing skills and deep experience in gaining market access.
Mining Inc () () revealed that an initial C$10 million exploration budget has been approved for 2021 at its flagship Johnson Tract polymetallic gold project in Alaska and plans for a 16,000 metre (m) drill program are already underway. The drilling, with three rigs, will target upgrading the JT deposit, along with adjacent target areas, and will see the first time testing of other prospects in the near 21,000 acre district. These include the new 1 kilometre (km) by 0.5 km high-grade silver-gold vein field, which was discovered in 2020 at the DC prospect, which sits 4 km northeast of the JT deposit.
Inc () () (FRA:JAM1) has struck a definitive deal with Danish biopharma DanCann Pharma for the distribution of three of its products in the Nordics and Germany, which is expected to generate over C$47.5 million in revenue for the Canadian biotech. The deal is for the exclusive distribution of Reduvo Adversa, QIXLEEF and ENJOUCA in Denmark, Norway, Sweden, Finland, and Germany. It includes upfront and milestone payments of up to C$1,5 million and the cumulative royalties on DanCann’s sales are expected to come in at more than C$46 million.
CytoDyn Inc () announced that it has struck an agreement to partner with the Academic Research Organization (ARO) – Albert Einstein Israelite Hospital (AEIH), in São Paulo, Brazil to run two trials with its flagship drug leronlimab (Vyrologix or PRO 140) on a small batch of critically ill coronavirus (COVID-19) patients, and a larger severely ill population. The Vancouver, Washington-based late-stage biotechnology company said the COVID-19 trials in Brazil are intended to provide the Brazilian regulatory authority, ANVISA, with “the requisite data” to consider making leronlimab available to thousands of Brazilians infected with COVID-19. These two Phase 3 trials will be conducted in up to 45 clinical sites, said the company.
Tartisan Nickel Corp () () (FRA:8TA) told investors it had begun preparing for a first pass drill program at the flagship Kenbridge nickel project in Ontario as the company updated on surface and borehole electromagnetic survey results. As previously reported, the company hired Crone Geophysics & Exploration Limited to perform a surface Time Domain Electromagnetic (TDEM) survey at Kenbridge North, which lies 2.5k kilometres (km) north of the Kenbridge deposit, as well as borehole geophysics at the known Kenbridge deposit.
Genprex Inc () (FRA:2DE) has received centralized Institutional Review Board (IRB) approval of the clinical trial protocol for its upcoming Acclaim-1 clinical trial in non-small cell lung cancer (NSCLC). Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines the company’s lead drug candidate, REQORSA immunogene therapy, with PLC’s () (NASDAQ:AZN) Tagrisso (osimertinib) in patients with late-stage NSCLC with mutated epidermal growth factor receptors (EGFRs) and whose disease progressed after treatment with Tagrisso.
Heritage Cannabis Holdings Corp () () (FRA:2UE) has announced the launch of ArthroCBD, an innovative hemp brand created to help people seeking “symptomatic relief.” Clinically tested ArthroCBD, is a softgel capsule with 25 mg of CBD and 6 mg of Beta caryophyllene. It is formulated using VESIsorb technology, which boosts absorption, compared to other oral CBD products on the market, said the company. The improved absorption levels result in “rapid onset of action and long-lasting relief,” Heritage Cannabis added. ArthroCBD has all traces of THC removed to avoid the adverse effects people sometimes suffer from other hemp-based products.
Goldseek Resources Inc () (FRA:4KG) (OTCMKTS:GSKKF) has announced its development strategy for the Beschefer project in Quebec, which is under a 100% earn-in agreement with () (OTCMKTS:WLBMF) (FRA:WC7). Goldseek said the best intersections on the property include 55.63 grams per ton (g/t) gold over 5.57 metres (m); 3.56 g/t gold over 28.4m; 10.28 g/t gold over 8m; and 12.40 g/t gold over 3.78m. The data review and modeling work will allow the company to put the best targets forward for its estimated 5,000-metres maiden drill program in 2021.
() () (FRA:4UY) announced it has employed the services of sports and entertainment consulting group SeventySix Capital Sports Advisory (SSCSA) to assist it in advancing its sportsbook platform expansion in the US. FansUnite said that by leveraging SSCSA’s extensive network of key partners, the company will be able to identify US sports, esports media and other companies and brands that are looking for a betting platform partner to provide wagering services to its followers.
() () (OTCPINK:EQTRF) said it has raised $1,432,087 since the February 5, 2021, closing of its most recent placement as a result of the exercise of 12,334,466 share purchase warrants that were issued in connection with several previous non-brokered private placements. The company noted that it currently has 59,126,224 warrants outstanding, with a weighted average exercise price of $0.20 and a weighted remaining contractual life of 1.32 years.
. () (OCTMKTS:ELECF) has said it plans to complete a private placement of up to 25,000,000 units of the company at a price of $0.40 each for proceeds of up to $10 million. The company said the proceeds will be used to fund royalty acquisitions as well as for general corporate working capital purposes. Each unit in the private placement is comprised of one common share of the company plus one common share purchase warrant. Each warrant can be exercised for a two-year period from the closing date at $0.60 per warrant share.
AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) announced that it has appointed veteran executive Fiona Fitzmaurice as its new CFO. Fitzmaurice brings more than 14 years of experience in accounting and financial control, the company said, serving both public and private companies. Fitzmaurice has previously worked as CFO of companies including , Pasofino Gold and Mojave Jane Brands. She also has extensive experience with corporate audits, prospectus filings, private placements, financings and corporate acquisitions. AgraFlora’s former CFO, Peter Nguyen, has amicably agreed to depart the company in order to “facilitate Ms. Fitzmaurice’s transition as the new steward of AgraFlora’s finances,” the company said.
Inc. () () has announced the appointment of Nathan Coyle, the company’s corporate controller as its interim chief financial officer with immediate effect, following the departure of Donal Carroll. The company noted that Coyle joined as corporate controller in 2020 and has 15 years of executive business experience as a finance leader in both public and private roles. He was previously with where he was a key player in restructuring the organization, shaping the growth and streamlining businesses within his industrial packaging segment.
Snowline Gold Corp () (OTCPINK:SNWGF) announced that it has appointed industry veteran and prominent geologist Dr Craig Hart as the chairman of the company’s board as the gold exploration company expands its projects in Yukon’s Selwyn Basin. Dr Hart was a founding geologist of the Yukon Geological Survey and former head of its Mineral Services division. Over a 14-year span, he undertook regional mapping and metallogenic surveys.
.() (FRA:8M0) has announced the appointment of Jeremi Fournier as a director of the company. The company noted that Fournier is president of Fournier & Fils, a successful Val D’Or-based general contractor with over 80 years of experience in the mining, environmental, industrial, commercial, and residential sectors. Prior to becoming president, he served as chief operating officer of the company.
. () (OTCQX:VMNGF) () announced that it has qualified to trade on the OTCQX Best Market and. has upgraded from the OTC Pink market, trading from today under the symbol VMNGF. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. In a statement, JC St-Amour, president and CEO of Vanstar Mining commented: “Our US investor base is an important group of shareholders and I am pleased to have upgraded to the OTCQX Market to provide more transparency and increase our exposure to one of the largest markets globally. Vanstar has several highly prospective gold properties in Quebec including our flagship property the Nelligan project which we jointly own and are developing with IAMGOLD. The Nelligan project hosts a world-class gold deposit, is located in one of the best mining jurisdictions in the world and is being jointly explored and developed by a successful and experienced mining Company, IAMGOLD. This year promises to be an exciting year for Vanstar with exploration results expected from Nelligan and our other gold properties.” () is the operator of financial markets for 11,000 US and global securities.
() (), a vertically-integrated cannabis consumer packaged goods company, announced that the company has determined not to proceed with the amendment put forth to extend the maturity date its 10% Senior Unsecured Convertible Debentures due September 14, 2021, to September 14, 2022. Accordingly, the company did not enter into a supplemental indenture with Odyssey Trust Company and the indenture remains unchanged.
Bioharvest Sciences Inc (CVE:BHSC) said it has been advised that Vivien Rakib, a major shareholder and a board member of the company intends to sell up to 7.7 million shares to Bioharvest’s chief executive officer, Ilan Sobel. The closing of this transaction is expected to be seven days from the notice filed today.
Ltd () said that further to the bulletin dated January 10, 2020, the TSX Venture Exchange has accepted for filing the company’s proposal to issue 2,054,794 shares at 73 cents per share to in settlement of an outstanding payment for $1.5 million, which is in connection with the share purchase agreement dated November 8, 2019, for the purchase of Minera Mandalay Challacollo Ltda.
() said the TSX Venture Exchange had accepted for filing the documentation relating to an agreement dated April 15, 2021, between the company and Inc., in connection with the option to acquire a 30% interest in the Hazeur property, located near Chibougamau in the north of the province of Quebec. As a result of the agreement, the company will be the legal and beneficial owner of a 100% interest in the property. Under the agreement, Tomagold will make a cash payment of $250,000 and issue two million common shares upon closing of the agreement. The vendor will retain a 2% net smelter return (NSR) royalty on any saleable production from the property; 50% of the NSR royalty (a 1% royalty) may be purchased by Tomagold for $500,000.
TomaGold also said the TSX Venture Exchange had accepted for filing the documentation relating to an agreement dated April 16, 2021, between the company and 2736-1179 Quebec Inc., Alain Darveau and Ovalbay Geological Services Inc., in connection with the option to acquire a 100% interest in the Obalski South block property, comprising 46 mining claims, located near Chibougamau in the north of the province of Quebec. Under the agreement, Tomagold will issue three million common shares upon closing of the agreement and will issue an additional two million common shares or make a cash payment of $250,000 one year after closing. The vendors will retain a 2% net smelter return (NSR) royalty on any saleable production from the property, 50% of the NSR royalty (a 1% royalty) may be purchased by the company for $1 million.
. () () () said it has been invited to present at the 41st Annual Growth Conference being held August 10-12, 2021. James Lanthier, CEO of Mindset, commented: “Mindset is pleased to be invited to present at ‘s Growth Conference. Mindset is at the forefront of the biggest opportunity in the nascent psychedelic medicine space, which is developing next-generation psychedelic therapeutics that aim to deliver the life-changing potential of psychedelic drugs through patentable, innovative chemical structures that make them more predictable, convenient and safer than first-generation psychedelics. We look forward to sharing the Mindset story with a wider investor audience and thank for the invitation.” For further information on Mindset, investors can visit the company website via the following link: www.mindsetpharma.com
Inc. () has announced that it plans to host a conference call at 8.30am Eastern Time on Friday, May 7, 2021, to discuss the company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for US callers or for international callers +1 973-528-0011 and using entry code 173027. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2585/41278 or on the company’s Investor Events section of the website. A webcast replay will be available on the Investor Events section of the company website – https://ir.orgenesis.com/events#/ – through Saturday, May 07, 2022. A telephone replay of the call will be available approximately one hour following the call, through Friday, May 21, 2021, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering conference ID: 41278.
Biocept, Inc. () has announced that it will release financial results for the three months ended March 31, 2021, after the market closes on Wednesday, May 12, 2021. The company said it will host a conference call for the investment community to discuss the results and answer questions at 4.30pm Eastern time (1.30pm Pacific time). Participants can pre-register for the conference call via the following link: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10155314&linkSecurityString=e72b599f50. Those who choose not to pre-register can access the live conference call by dialing the following numbers and requesting the Biocept call: US Callers 855-656-0927; Canadian Callers 855-669-9657; Other International Callers 412-902-4109. A live webcast of the call will be available at https://ir.biocept.com/. The webcast will be archived for 90 days. A replay of the conference call will be available for 48 hours following the conclusion of the call by dialing (877) 344-7529 for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for other international callers, and entering the replay access code 10155314.
Phunware, Inc. () has said it will hold a conference call on Thursday, May 13, 2021, at 5.00pm Eastern time (2.00pm Pacific time) to discuss its financial results for the first quarter ended March 31, 2021, which will be issued in a press release prior to the call. Phunware management will host the conference call, followed by a question and answer period. Dial-in details are: US dial-in: 844-369-8770; International dial-in: 862-298-0840. The conference call will be broadcast live and available for replay via the following link, https://www.webcaster4.com/Webcast/Page/2562/41245, and via the investor relations section of the company’s website.
, Inc. () has announced that its chief executive officer Saiid Zarrabian will participate at the Benzinga Global Small Cap Conference on May 14, 2021. The company said Zarrabian will deliver his corporate presentation at 12.25 pm ET on May 14, 2021. Investors can also request a one-on-one meeting with Zarrabian to be arranged following the conclusion of the conference. Investors can register for the conference via the following link: https://www.benzinga.com/events/small-cap/global
() () has announced its placement in an editorial published by NetworkNewsWire, one of 50+ trusted brands within the InvestorBrandNetwork (IBN), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “COVID-19 and Martech’s Law: Companies Close Gap, Digital Advertisers Thrive,” investors can use the following link: https://nnw.fm/zeoI7
(), the operator of financial markets for 11,000 U.S. and global securities, has announced that . () (OTCQX:RCKTF), a lithium development and chemical technology company, has qualified to trade on the OTCQX Best Market and has today upgraded to from the OTC Pink market. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. “The rapidly growing global electric vehicle and energy storage markets have significantly increased US-based investor interest in the battery supply chain, especially with respect to the critical minerals underpinning these new technologies,” said Dirk Harbecke, Rock Tech’s chairman. “We aim to broaden our reach within the North American investing community as we achieve several exciting milestones in the coming months.”